Craig Safian
Analyst · William Blair. Your line is open
Thank you, Gene, and good morning, everyone. 2018 was an exciting year for Gartner. It was the first full year of providing insight and advice to clients across all enterprise functions giving us a much broader addressable market and the ability to provide even more value to our clients. On FX-neutral basis, our year-over-year financial performance for 2018 included: total contract value growth of 11%; total company revenue growth of 12%; adjusted EBITDA growth of 9%; diluted adjusted earnings per share of $3.63 and free cash flow of $468 million. Demand for our services remains robust around the world. And in the fourth quarter, we delivered excellent financial results across our three operating segments. As our 2019 outlook demonstrates, we expect to deliver double digit in FX-neutral revenue and EBITDA growth with strong cash flow generation. Fourth quarter revenue was $1.1 billion, up 10% on a reported basis, and 12% on an FX-neutral basis. We also delivered contribution margin of 63%, up about 24 basis points from the prior year, EBITDA of $211 million, up 6% year-over-year and 6% FX-neutral and adjusted EPS was $1.20. Free cash flow in the quarter was $7 million modestly ahead of expectations as some major CapEx projects slipped into 2019. Our Research business had another excellent quarter. Research revenue grew 9% in the fourth quarter and 11% on an FX-neutral basis. Total contract value was $3.2 billion at December 31st, growth of 11.4% versus the prior year. We always report contract value growth in FX-neutral terms. For the full year of 2018, Research revenues increased by 13% on a reported basis and 12% on an FX-neutral basis. The growth contribution margin for Research was 69.1% consistent with prior years. On Page 9 of the earnings supplement, you will see details of GTS performance overtime. In the fourth quarter, GTS contract value increased 14% versus the prior year accelerating its growth rate both sequentially and year-over-year. GTS had contract value of $2.6 billion at year-end. Client retentions for GTS remained strong at 83%. Wallet retention for GTS was 105% for the quarter, up 70 basis points year-over-year, and the highest we've reported for GTS. These retention rates reflect client spending more with us each and every year. GTS new business grew 14% versus the fourth quarter of last year. We continue to see a mix of new business across new clients, sales of additional services and upgrades through existing clients. We ended the fourth quarter with 12,998 GTS clients, up 6% compared to Q4 of 2017. The average contract value for enterprise also continues to grow. They now stand at $197,000 for enterprise and GTS, up 8%. This continued and consistent increase in average spends reflects our ability to drive CV growth both through new and the existing enterprises. Average spend for enterprise has increased consistently over the past several years, but our average enterprise still only has five to six weeks meaning we still have plenty of incremental penetration opportunities within our existing clients. The investments we have made over the past two years to improve sales force productivity continue to pay off with an increase again in this quarter. For GTS, the year-over-year net contract value increase, or NCVI, divided by the beginning in period quota-bearing headcount was $118,000 per salesperson, up 7% versus the fourth quarter of last year. This is the fifth consecutive quarter of year-over-year productivity improvement. The combination of headcount growth and productivity improvements led to GTS accelerating its growth rate over the course of 2018. Turning to GBS. As you heard from Gene, our focus in 2018 was on building the foundation for future sustained double-digit growth in GBS CV. All of our GBS metrics reflected discontinuation of sales of the largest legacy products. As Gene described the discontinuations have been based on a purposeful strategy that allows our sales teams to focus on GXL products going forward. GBS contract value finished the year at $607 million, up 1% versus 2017. As Gene also discussed, the future of GBS is our GXL products. Looking at total contract value from the GXL products, we drove an increase of 79% year-over-year, from $109 million to $195 million, from 2017 to 2018. Just in the fourth quarter, in HR and Finance together, we generated $30 million of new CV. On Page 10 of our earnings supplement, you will see the usual summary of GBS metrics. GBS client retention was 82% for the quarter. GBS wallet retention was 95%, down from 100% last year. New business declined by 11% in the quarter versus the prior year. We ended the fourth quarter with 5,451 GBS clients, down about 4% versus the prior year period. For GBS, productivity declined significantly. The year-over-year net contract value increase, or NCVI, provided by the beginning period quota-bearing headcount was $10,000. The average contract value per enterprise at GBS increased about 5% to $111,000. Those were the headline results. However, they have secured what is really happening as we make the transition to GXL products. To drill down, we provided some more details than usual this quarter and you’ll find the data that will reference included in the earnings supplement. On Page 11, you’ll see the bridge from 2016 GBS CV to 2018 GBS CV. Shown in grey and on the bottom left of the page, you’ll see that new business for the legacy products declined by $81 million in 2018, as we made the strategic decision to discontinue new sales of those products in favor of the new GXL products. The chart on the top left depicts the most important development, growth of new business and the new GXL products. We sold over $100 million worth of GXL new business over the course of 2018, an increase of 176%. And that number obviously ramped over the course of the year as our frontline sellers started making the transition to selling GXL products. The drivers of future GBS growth are the same as they are for GTS, headcount and sales productivity. Improvements and increases in both leads to revenue, profits and cash flow. In 2018, we grew our sales force 23%, which is an addition to growing 16% during 2017. As this larger sales force continues gaining experience, they will drive accelerated growth. Productivity in turn increases when new business improves, retention improves or both. While we typically combine new business and attrition in our reporting, we're breaking them out this quarter to help you see what's going on below the headline numbers. New business productivity for GBS overall, a complete measure of how much the GBS sales team is selling is calculated as trailing 12-month new business provided by opening period headcount. This is comparable to the methodology we use for our longstanding productivity measure. On this measure, we ended 2018 at more than $260,000 of new business for sales person. New business productivity for GXL continues to ramp as the team has had more time with the newest products since we started introducing them late in 2017. In 2018, which was only a partial year for most of the practice areas, the team sold more than $100 million of GXL new business. That compares to $37 million last year. Almost half of 2018's new sales are from products that didn't pilot or fully launched until late 2017. The one other thing to note is that legacy new business will not be going to zero. While we have launched GXL products in all the primary functional areas, there are still leadership councils that will continue to have new business until we launch the replacement GXL products. As we shift more of the CV to the GXL products, we expect high retention rates. While legacy GBS CV attrition is close to 30%, GXL attrition is around 20%, almost at GTS levels. Exiting 2018 on a blended basis, that's about 27% attrition. There is still opportunity to reduce attrition, and we've expanded our service teams because we know great engagement meets the better retention. The underlying drivers of the engagement are the individualized content and service than an enterprise license does not facilitate as naturally. As the attrition rate moves from just under 30% towards the GXL rate or even lower, we will see growth accelerating. With the success that the GBS team is having with the new GXL products, their high retention levels, programs we have in place to drive incremental improvements of retention and the stability in the organization and strategy as we enter 2019, we continue to manage towards double-digit CV growth by the end of this year. On Page 12 of the supplement, we outlined a high level model to help you think about the path to double digit CV growth the way we do. You can see the sensitivity to improvements and new business productivity and retention. We get the double digit growth through a combination of more sales people already onboard and with more tenure of better product mix for retention, broader retention programs in place and a compelling set of new products. If we don't make any improvements in new business productivity or attrition, GBS CV will grow about 8% in 2019. Of course, we are focused on continuous improvement and innovation. For every 100 basis points improvement in attrition, we will see 100 basis points improvement in growth. For every $7,500 improvement in new business productivity, we will see a 100-basis-point improvement in growth. That's only a 3% improvement. Looking back at the Research business in 2018, GTS had an outstanding year with increases in wallet retention, sales productivity and accelerating contract value. We are seeing returns on the increased spending we did in 2017 and 2018. For GVS, while CV decelerated in the quarter, we have built the foundations for the future. The market validated the products value propositions and sales teams have made tremendous progress adapting to the new products and our go-to-market approach. In Conferences, revenues increased by 16% year-on-year in Q4 to $196 million. FX-neutral growth was 18%. We had 15 destination conferences in the fourth quarter consistent with last year. On a same conference FX-neutral basis, revenues were up 18% with an 11% increase in same conference attendees. For the full year 2018, revenue increased by 19% on both reported and FX-neutral basis. Gross contribution margin for the year was 50%, an increase of about 190 basis points from 2017. As you know, we made a number of investments in support of our conference business in 2017. Those investments paid off as Conferences had its best year ever. Fourth quarter Consulting revenue is increased by 12% to $96 million. FX-neutral growth was about 14%. Labor-based revenues were $74 million. In our labor-based business, revenues increased 3% versus Q4 of last year or 4% on an FX-neutral basis. On the Labor-based side global headcount of 738 was up 8%, and we had 141 managing partners at the end of Q4, up about 3% versus the prior year. Utilization of 61% was affected by Europe where we had lower levels of backlog. The backlog position in Europe improved as we exited 2018. Overall, backlog ended the quarter at $111 million, up 12% year-over-year on an FX-neutral basis. Our bookings performance remained strong and our 2019 pipeline is encouraging. The contract optimization business was up over 60% versus the prior year quarter. For the full year, Consulting revenue increased by 8%, or 7% FX-neutral, and its gross contribution of 29%, was up 40 basis points compared to 2017. As I mentioned earlier, the overall gross margins for the whole business improved by approximately 24 basis points in Q4 and over 60 basis points for the full year of 2018. SG&A increased 12% year-over-year in the fourth quarter or 14% on an FX-neutral basis. We continue to grow sales capacity and the enabling infrastructure to support our strategy of delivering sustained double-digit growth over the long-term. The enabling infrastructure includes investments in human resources functions like recruiting and real estate to support the increased number of associates around the world. Our sales force continues to be our largest investment. And at the end of the fourth quarter, we had 3,894 quota-bearing associates in Research. This includes 3,100 foreign GTS and 790 in GBS, for growth of 15% and 23% respectively. For the full year, SG&A grew 16% on a reported basis and 15% FX-neutral. G&A, which represents about one third of the SG&A, grew about 9%, as we continue to see modest operating leverage in G&A, leverage that we can reinvest in other areas to support and drive growth. We've made a number of investments across our selling teams over the course of 2017 and 2018. And our results in 2018, shows some of the returns we've been getting for those investments. In GTS, we've made investments to increase territories, reduce open rolls and to drive improvements in sales productivity. In 2018, we saw improvements of productivity and the growth rate of CV accelerated. In the incremental CV, we gained from these investments has value beyond just one year. Similarly in our Conferences business, we invested in increasing territories, reducing open territories and management and selling infrastructure for the advent of business. These investments supported almost a doubling of our growth rate in 2018. And we are expecting the same sorts of returns from our investments in GBS. We're investing in growing sales force, improving service and launching new products, which we believe will translate to double-digit contract value growth in 2019, and even faster than that in the future. Adjusted EBITDA for the fourth quarter was $211 million, up 6% on both reported and FX neutral basis. Depreciation was about flat with last year, and amortization took an expected to step down from $53 million to $34 million as some of the acquisition intangibles reached their 18-months life. Integration expenses were down year-over-year as we have moved past the biggest part of the integration work. Interest expense in the quarter was $25 million, down from $36 million in the fourth quarter of 2017. The lower interest expense resulted from paying down debt over the past year. The Q4 adjusted tax rate, which we used for the calculation of adjusted net income, was 30.6% for the quarter. This was higher than expected largely due to audit settlements and increased non-deductible expenses. The tax rate for the items due to adjusted net income was 45.3% a quarter. Adjusted EPS in Q4 was $1.20. For the full year, adjusted EPS was $3.63, excluding divested operations. In Q4, operating cash flow was $45 million compared to $22 million last year. The increase in operating cash flow was driven by solid operating results, lower interest expense and improvements in working capital. Q4, 2018 CapEx was $62 million and Q4 cash acquisition and integration payments and other non-recurring items were approximately $24 million, about $18 million of CapEx we have planned for the fourth quarter slipped into 2019. Free cash flow for the full year was $468 million, which is up more than 36% versus the prior year on a combined basis. 2018 was a very strong free cash flow year for us, but there are few items, all of which we've discussed in the past needs to be aware of. First, the 2018 results include a roughly $40 million catch-up on collections, which should have occurred during 2017. The reported figure also included the free cash flows of a number of divested operations related to the periods prior to closing. We estimate roughly $19 million of an impact there. Taking those adjustments into account, our ongoing 2018 free cash flow would have been $409 million. 2018 was a strong free cash flow year. Our December 31st debt balance was about $2.3 billion. Our debt is now 95% fixed rate. Our gross leverage on a reported basis is up 3.2 times. Adjusted EBITDA for the divestitures, our gross leverage ratio is now about 3.4x EBITDA. We – some of our capacity can take advantage of the decline in the stock price in the fourth quarter, repurchasing of $156 million of our stock. Our capital allocation strategy remains the same. We deploy our free cash flow and balance sheet flexibility on strategic value enhancing M&A, and returning capital to our shareholders through our buyback programs. We have over $850 million remaining on our share repurchase authorization. Turning to the outlook for 2019. Having completed the divestitures in the fourth quarter, we again provided you with a set of non-GAAP financials we use to evaluate the business. We expect to share this incremental information on an ongoing basis. Before jumping into the details, I wanted to give you the context how we approached our 2019 guidance and how we are operationalizing what Gene and I have discussed this morning. First, our 2018 ending contract value and corresponding growth rate drives the bulk of our 2019 Research revenues. As CV grows over the course of the year it does positively impact revenue, but growth in Q3 and Q4 has a more muted impact on the current year revenue line. I’d also note that there is a slight headwind to our research and total revenue growth rates caused by product retirements. Second, advance bookings and consulting backlog are the metrics that drive our Conference and Consulting revenue guidance. As mentioned earlier, we had very strong advanced bookings in our Conference business, and our Consulting backlog is up 12% year-over-year and during 2019. Third, we continue to invest to support and drive the future growth of our business. After a surge in investing, 2019 will be closer to our typical run rate. Our 2019 plan cost for 11% territory growth in GTS, while maintaining our record low level of open territories, and roughly 14% to 16% territory growth for GBS. We have decided to moderate the growth in GBS, so that we can focus on getting all of our sales teams further up the lending curve with fewer distractions. The territory growth in GBS is predominantly in areas where we have already achieved strong productivity. We continue to invest in our enabling infrastructure functions, but we again plan to grow them at a slower rate in revenue in 2019. And lastly, our guidance reflects recent FX rates. The dollar strengthened over the course of 2018, and FX was causing roughly two point negative impacts to our projected 2019 growth rates across revenues, adjusted EBITDA, adjusted EPS and free cash flows. The highlights of our full year 2019 guidance are as follows. We expect adjusted revenues of approximately $4.2 billion to $4.3 billion, those FX-neutral growth of 10% to 13%. In addition to the non-core businesses that we divested over the course of 2018, there were some additional products from the CEB acquisition that we viewed as non-core. We have retired these, which is impacting our 2019 total revenue growth by about 75 basis points. We expect adjusted EBITDA of $720 million to $765 million, FX-neutral growth of 7% to 13%. We expect an adjusted tax rate of around 25.5% for 2019. Please note that if you are adding back from GAAP net income, the rate for the tax affect on the add backs was about 23.5%. We expect 2019 adjusted EPS of between $3.82 and $4.19 per share, FX-neutral growth of approximately 7% to 15%. For 2019, we expect free cash flow of $455 million to $485 million. That is projected FX-neutral growth of 11% to 19% off of our normalized 2018 free cash flow. All the details of our guidance are included on our Investor Relations site. It is also important to note that we have revalued our contract value at current year FX rates. Our 2018 ending contract value at 2019 FX rates, is $2.5 billion for GTS and $594 million for GBS. Details are included in the appendix of the earnings supplement. Lastly on guidance, I'd like to provide some additional information to allow for an understanding of the seasonality and other factors that will impact our revenue and earnings on a quarterly basis. For 2019, we expect our quarterly revenue phasing to be roughly consistent with adjusted revenue phasing from 2018. Q1 will be a little lighter than 2018 as a percent of the full year, impacted by a stronger than normal Q1, 2018. This is also the quarter with the most pronounced impact of product retirements. For the first quarter of 2019, we expect adjusted EPS of between $0.50 and $0.54. Q1 EPS is impacted by slightly lower proportion of revenues, higher depreciation and foreign exchange. Our strong 2018 financial and operating performance across all of our operating segments continued in the fourth quarter. Notably our strong GTS contract value growth of 14% accelerated over the course of the year and sales of our new GXL products and GBS continue to scale. Our Conferences and Consulting businesses both had strong years. Free cash flow improved significantly in the year. We have divested all the identified non-core assets and used those proceeds to rapidly delever, reducing our debt balance by $1 billion in 2018. And we've resumed our share repurchase program buying over $260 million of our stock in 2018. The trends going into 2019 are strong and our teams are executing the plan. We are applying the Gartner growth formula across the combined business to drive sustained long-term double-digit growth to revenues, EBITDA and free cash flow. With that, I'll turn the call back over to the operator and we'll be happy to take your questions. Operator?